Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma

Histopathology

Volumn 36, Issue 2, 2000, Pages 161-167

  Alanen, K ^a   Deng, D X ^a   Chakrabarti, S ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Breast; Carcinoma; Endothelin 1; Endothelin 3; Endothelin B receptor

Indexed keywords

ANTIBODY; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN B RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CARCINOMA; BREAST FIBROADENOMA; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; ENDOTHELIN-1; ENDOTHELIN-3; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034000607     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00795.x     Document Type: Article

References (44)

1. 1. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332; 411-415.
2. 2. Krum H, Reuven JV, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. NEJM 1998; 338; 784-790.
3. 3. Ergul A, Glassburg MK, Majercik MH, Puett D. Endothelin-1 promotes steroidogenesis and stimulates protooncogene expression in transformed murine Leydig cells. Endocrinology 1993; 132; 598-603.
4. 4. MacCumber MW, Ross CA, Glaser BM, Snyder SH. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. 1989; 86; 7285-7289.
5. 5. MacCumber MW, Jampel HD, Snyder SH. Ocular effects of endothelins: abundant peptides in the eye. Arch. Ophthalmol. 1991; 109; 705-709.
6. 6. Imokawa G, Kobayashi T, Miyagishi M, Higashi K, Yada Y. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res. 1997; 10; 218-228.
7. 7. Kurihara Y, Kurihara H, Suzuki T et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994; 368; 703-710.
8. 8. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol. 1990; 258; C408-C415.
9. 9. Takuwa N, Takuwa Y, Yanagisawa M, Yamashita K, Masaki T. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. J. Biol. Chem. 1989; 264; 7856-7861.
10. + exchange, c-fos expression and mitogenesis in rat mesangial cells. J. Clin. Invest. 1989; 83; 708-712.
11. 11. Patel KV, Schrey MR. Endothelins in breast cancer. Cancer Treat. Res. 1996; 83; 369-394.
12. 12. Baley PA, Resnik TJ, Eppenberger U, Hahn AW. Endothelin messenger RNA and receptors are differentially expressed in cultured human breast cancer epithelial and stromal cells. J. Clin. Invest. 1990; 85; 1320-1323.
13. 13. Vigne P, Marsault R, Breitmayer JP, Frelin C. ET stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem. J. 1990; 266; 415-420.
14. 14. Asano T, Aoyagi M, Hirakawa K, Ikawa Y. Effect of endothelin-1 as growth factor on a human glioma cell line; its characteristic promotion of DNA synthesis. J. Neurooncol. 1993; 18; 1-7.
15. 15. Mazzocchi G, Rossi GP, Rebuffat P, Malendowicz LK, Markowska A, Nussdorfer GG. Endothelins stimulate deoxyribonucleic acid synthesis and cell proliferation in rat adrenal zona glomerulosa acting through an endothelin-A receptor coupled with protein kinase C-and tyrosine kinase-dependent signaling pathways. Endocrinology 1997; 138; 2333-2337.
16. 16. Takagi Y, Fukasea M, Takata S, Yoshimi H, Tokunaga O, Fujita T. Autocrine effect of endothelin on DNA synthesis in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 1990; 168; 537-543.
17. 17. Lahav R, Ziller C, Dupin E, Le Dourain NM. Endothelin 3 promotes neural crest cell proliferation and mediates a vast increase in melanocyte number in culture. Proc. Natl. Acad. Sci. 1996; 93; 3892-3897.
18. 18. Pedram A, Razandi M, Hu M, Levin ER. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J. Biol. Chem. 1997; 272; 17097-17103.
19. 19. Stiles JD, Ostrow PT, Balos LL et al. Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J. Neuropathol Exp. Neurol. 1997; 56; 435-439.
20. 20. Yamashita J, Ogawa M, Inada K, Yamashita S, Matsuo S, Takano S. A large amount of endothelin-1 is present in human breast cancer tissues. Res. Commun. Chem. Pathol. Pharmacol. 1991; 74; 363-370.
21. 21. Nelson JB, Chan-Tack K, Hedican SP et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res. 1996; 56; 663-668.
22. 22. Kar S, Yousem SA, Carr BI. Endothelin-1 expression by human hepatocellular carcinoma. Biochem. Biophys. Res. Comm 1995; 216; 514-519.
23. 23. Pagotto U, Arzberger T, Hopfner U et al. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J. Clin. Invest. 1995; 96; 2017-2025.
24. 24. Yamashita J, Ogawa M, Matsuo S, Kiyohara H, Inada K, Yamashita S. Abundant expression of immunoreactive endothelin 1 in mammary phyllodes tumors: possible paracrine role of endothelin 1 in the growth of stromal cells in phyllodes tumor. Cancer Res. 1992; 52; 4046-4049.
25. 25. Kojima K, Nihei Z. Expression of endothelin-1 immunoreactivity in breast cancer. Surg. Oncol. 1995; 4; 309-315.
26. 26. Yamashita J, Ogawa M, Sakai K. Prognostic significance of three novel biologic factors in a clinical trial of adjuvant therapy for node-negative breast cancer. Surgery 1995; 117; 601-608.
27. 27. Pekonen F, Nyman T, Ammala M, Rutanen EM. Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Br. J. Cancer 1995; 71; 59-63.
28. 28. Chakrabarti S, Sima AAF. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diabetes Res. Clin. Pract. 1997; 37; 109-120.
29. 29. Sakurai T, Yanagisawa M, Inoue A et al. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Comm. 1991; 175; 44-47.
30. 3 0. Terada Y, Tomita K, Nonoguchi H, Yang T, Marumo F. Expression of endothelin-3 mRNA along rat nephron segments using polymerase chain reaction. Kid. Int. 1993; 44; 1273-1280.
31. 31. Shiba R, Sakurai T, Yamada G et al. Cloning and expression of rat preproendothelin-3 cDNA. Biophys. Res. Comm. 1992; 486; 588-594.
32. 32. Lin HY, Kaji EH, Winkel GK, Ives HE, Lodish HF. Cloning and expression of a vascular smooth muscle endothelin 1 receptor. Proc. Natl. Acad. Sci. 1991; 88; 3185-3189.
33. 33. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348; 730-732.
34. 34. Wang X, Douglas SA, Feuerstein GZ, Ohlstein EH. Temporal expression of ECE-1,ET-1,ET-3, ETA and ETB receptor mRNA after balloon angioplasty in the rat. J. Cardiovasc. Pharmacol. 1995; 26 (Suppl. 3); S22-S25.
35. 35. Kusafuka T, Wang Y, Puri P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschprung's disease. Hum. Mol. Genet. 1996; 5; 347-349.
36. 36. Yamashita J, Ogawa M, Nomura K et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res. 1993; 53; 464-467.
37. 3 7. Schrey MP, Patel KV, Tezapsidis N. Bombesin and glucocortiocoids stimulate human breast cancer cells to produce endothelin, a paracrine mitogen for breast stromal cells. Cancer Res. 1992; 52; 1786-1790.
38. 38. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med. 1989; 170; 1649-1669.
39. 39. Tamm I, Cardinale I, Murphy JS. Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc. Natl. Acad. Sci. 1991; 88; 4414-4418.
40. 40. Pruis J, Emeis JJ. Endothelin-1 and endothelin-3 induce the release of tissue-type plasminogen activator and von Willebrand factor from endothelial cells. Eur. J. Pharmacol. 1990; 187; 105-112.
41. 41. Schrey MP, Patel KV. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br. J. Cancer 1995; 72; 1412-1419.
42. 42. Nelson JB, Hedican SP, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat. Med. 1995; 1; 944-949.
43. 43. Inagaki H, Bishop AE, Tadaaki E, Polak JM. Autoradiographic localization of endothelin-1 binding sites in human colonic cancer tissue. J. Pathol. 1992; 168; 263-267.
44. 44. Kikuchi K, Nakagawa H, Kadono T et al. Decreased ET (B) receptor expression in human metastatic melanoma cells. Biochem. Biophys. Res. Comm. 1996; 219; 734-739.